
Sign up to save your podcasts
Or
After decades of failed drug trials, two new drugs have emerged in slowing memory loss associated with Alzheimer's disease: Leqembi and Donanemab. In Episode #015 I deep dive into novel Alzheimer's therapies to discuss their effectiveness, safety, and how to find out if you're at risk.
Chapters:
(0:00) Introduction
(2:00) Who's most at risk of Alzheimer's Disease?
(5:52) The Amyloid Hypothesis
(7:14) Leqembi approved by FDA
(9:16) Donanenmab may be next
(12:10) Alzheimer's drugs, brain bleeding, and death
(16:01) How do you know if you have Alzheimer's?
(21:20) Dementia and CTE
(22:49) Do taking smart drugs make us more productive? Is it worth the risk?
(27:00) The Connect - viewers' comments from previous episodes
Show Notes:
Alzheimer’s drug being tested Leqembi or Lecanemab
https://www.abc.net.au/news/2023-07-07/alzheimer-s-disease-drug-leqembi-gets-green-light-in-us/102575974
Donanemab:
https://www.abc.net.au/news/2023-05-04/eli-lilly-drug-alzheimer-cognitive-decline-by-35-per-cent/102301474
Systematic failure of Alzheimer’s drug trials:
https://www.abc.net.au/news/health/2020-02-26/alzheimers-drug-failure-raises-questions-about-research/11996258
Are these drugs safe?
https://www.science.org/content/article/alzheimer-s-trial-shows-clear-benefits-and-significant-risks-eli-lilly-antibody
Symptoms of Alzheimer’s:
https://www.dementia.org.au/about-dementia/types-of-dementia/alzheimers-disease?gclid=Cj0KCQjwzdOlBhCNARIsAPMwjbz46yEPHVQnD-rqxwHOQrtlHnD2gWQdBRIGW9fc-bDlQzjxd2M-TfgaAvMOEALw_wcB
Mini Mental State Examination (MMSE)
https://cgatoolkit.ca/Uploads/ContentDocuments/MMSE.pdf
CTE in female athlete:
https://theconversation.com/australian-researchers-confirm-worlds-first-case-of-dementia-linked-to-repetitive-brain-trauma-in-a-female-athlete-208929
Smart drugs make you dumb:
https://theconversation.com/smart-drugs-make-you-worse-at-solving-complex-problems-new-study-finds-207711
Thanks for reading BioLab Collective with Jack Wang! Subscribe for free to receive new posts and support my work.
After decades of failed drug trials, two new drugs have emerged in slowing memory loss associated with Alzheimer's disease: Leqembi and Donanemab. In Episode #015 I deep dive into novel Alzheimer's therapies to discuss their effectiveness, safety, and how to find out if you're at risk.
Chapters:
(0:00) Introduction
(2:00) Who's most at risk of Alzheimer's Disease?
(5:52) The Amyloid Hypothesis
(7:14) Leqembi approved by FDA
(9:16) Donanenmab may be next
(12:10) Alzheimer's drugs, brain bleeding, and death
(16:01) How do you know if you have Alzheimer's?
(21:20) Dementia and CTE
(22:49) Do taking smart drugs make us more productive? Is it worth the risk?
(27:00) The Connect - viewers' comments from previous episodes
Show Notes:
Alzheimer’s drug being tested Leqembi or Lecanemab
https://www.abc.net.au/news/2023-07-07/alzheimer-s-disease-drug-leqembi-gets-green-light-in-us/102575974
Donanemab:
https://www.abc.net.au/news/2023-05-04/eli-lilly-drug-alzheimer-cognitive-decline-by-35-per-cent/102301474
Systematic failure of Alzheimer’s drug trials:
https://www.abc.net.au/news/health/2020-02-26/alzheimers-drug-failure-raises-questions-about-research/11996258
Are these drugs safe?
https://www.science.org/content/article/alzheimer-s-trial-shows-clear-benefits-and-significant-risks-eli-lilly-antibody
Symptoms of Alzheimer’s:
https://www.dementia.org.au/about-dementia/types-of-dementia/alzheimers-disease?gclid=Cj0KCQjwzdOlBhCNARIsAPMwjbz46yEPHVQnD-rqxwHOQrtlHnD2gWQdBRIGW9fc-bDlQzjxd2M-TfgaAvMOEALw_wcB
Mini Mental State Examination (MMSE)
https://cgatoolkit.ca/Uploads/ContentDocuments/MMSE.pdf
CTE in female athlete:
https://theconversation.com/australian-researchers-confirm-worlds-first-case-of-dementia-linked-to-repetitive-brain-trauma-in-a-female-athlete-208929
Smart drugs make you dumb:
https://theconversation.com/smart-drugs-make-you-worse-at-solving-complex-problems-new-study-finds-207711
Thanks for reading BioLab Collective with Jack Wang! Subscribe for free to receive new posts and support my work.